Changes to the Executive Leadership Team
20 Diciembre 2017 - 4:59AM
Changes to the Executive Leadership Team
Novozymes announces the appointment of Ms.
Prisca Havranek-Kosicek as new Chief Financial Officer effective
February 1, 2018.
Ms. Havranek-Kosicek has up until November 2017
served as CFO and member of the Executive Board for Kuoni Group, a
leading 8,000-employee service provider to the global travel
industry. In the period 2011-2016 Ms. Havranek-Kosicek held
positions at Royal DSM, including Group Treasurer and CFO for DSM’s
pharmaceutical division, and from 2004-2008 she served as VP
Corporate Subsidiaries and Investor Relations for Austrian Airlines
Group.
CEO Peder Holk Nielsen says: “With a strong
business acumen from international positions around the world, a
thorough understanding of the different finance functions and
knowledge of Novozymes’ markets, Prisca brings the right
competencies and drive to support our future growth. I'm very
pleased to see her become part of our Executive Leadership
Team.”
Ms. Prisca Havranek-Kosicek says: “I'm honored
to join Novozymes, the global leader in biological solutions with a
strong cultural heritage and values. What sets Novozymes apart is
the company’s innovation track record and its commitment to help
solve some of the pressing global challenges facing the world
today. I look forward to working with the great people at Novozymes
to continue this journey.”
Ms. Havranek-Kosicek (1975) is an Austrian
citizen. She currently lives in Zurich, Switzerland, and will
relocate to Denmark during 2018 with her family. She has previously
worked in Austria, Germany, the Netherlands, Malaysia and the
US.
Ms. Havranek-Kosicek holds a Ph.D. in Business
Administration from the Vienna University of Economics and
Business. She serves as member of the Supervisory Board of Allianz
Elementar Versicherungs-AG and Allianz Elementar
Lebensversicherungs-AG.
Ms. Havranek-Kosicek will take part in the
2017-2019 Executive Leadership Team’s incentive program on a
proportional basis from February 1, 2018. A description of this
program, introduced on January 18, 2017, can be found in the “Group
financial statement for 2016. Company announcement No. 1.”
http://prlibrary-eu.nasdaq.com/Resource/Download/09e836df-9adc-4d15-8857-157ba3cb458f